Results 221 to 230 of about 153,362 (337)

The DAHANCA 27 Phase II Study: Transoral Laser Microsurgery for T1aN0M0 Glottic Squamous Cell Carcinoma, a Comparison to Accelerated Radiotherapy

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction Endoscopic surgery of T1a glottic squamous cell carcinoma (SCC) is believed to have advantages compared to radiotherapy (RT), including short duration, cost‐effectiveness, repeatability, and RT reserved for second tumors/failures. The equality of tumor control probability after treatments is unresolved.
Nina M. Lyhne   +7 more
wiley   +1 more source

Health‐Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed‐Methods Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Patients with head and neck sarcomas (HNS) face unique health‐related quality of life (HRQoL) challenges due to its disease rarity. This study examined and identified the prevalence of generic‐ and location‐specific HRQoL issues.
E. Koffi   +25 more
wiley   +1 more source

Ear, nose and throat (ENT) manifestations and complications of reflux. [PDF]

open access: yesFrontline Gastroenterol, 2022
Brar S   +4 more
europepmc   +1 more source

In Silico Modeling of Safe Force Limits for Trismus Therapy Following Jaw Reconstruction

open access: yesHead &Neck, EarlyView.
ABSTRACT Background and Objective Restricted mouth opening (trismus) is a common complication following segmental mandibulectomy and autologous bone reconstruction. However, the biomechanical limits of reconstructed mandibles, particularly in cases without bone union, remain poorly understood.
Masoud Mohseni‐Dargah   +8 more
wiley   +1 more source

Patient-centered approaches to communicating ear, nose, and throat advancements: Bridging the knowledge gap. [PDF]

open access: yesJ Family Med Prim Care
Salunkhe RM   +4 more
europepmc   +1 more source

Self-medication practices with conventional and herbal drugs among ear, nose, and throat patients. [PDF]

open access: yesRev Assoc Med Bras (1992), 2022
Kıroğlu O   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy